This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 September - 3 October 2020 and includes updates on COVID-19 associated with SARS-CoV-2, West Nile virus, Ebola virus disease - eleventh outbreak in the Democratic Republic of the Congo, avian influenza and cholera.
The aim of this document is to describe COVID-19 clusters and outbreaks in the EU/EEA and the UK linked to occupational settings, including healthcare and non-healthcare settings, and to identify possible factors contributing to transmission in these settings.
This document aims to provide guidance for civil society and non-governmental organisations (NGOs) as well as for national and regional authorities in the EU/EEA and the UK, who are providing support for people who have medical and social vulnerabilities during the COVID-19 pandemic.
This document aims to provide scientific evidence and guidance for healthcare settings and the public on using gloves as a preventive measure during the COVID-19 pandemic.
This document provides an overview of the evidence on the available methods for decontaminating respirators or filtering face pieces (FFP), in the event of shortages, used in healthcare settings providing care to possible, probable or confirmed COVID-19 patients.
This issue of the CDTR (Communicable Disease Threats Report) covers the period from 24-30 May 2020 and includes updates on COVID-19, Ebola fever and influenza.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2020 and includes updates on Ebola virus disease, COVID-19 associatd with SARS-CoV-2, influenza season 2019-2020, Ebola virus disease in the Demoratic Republic of the Congo 2018-2020 and influenza A(H9N2).